Trial Profile

A Multi-center, Single-blind, Randomized, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Adding CARTISTEM on Microfracture in Patients With Talar Chondral or Osteochondral Defect

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 28 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

18 Mar 2023 According to a Medipost media release, company announced that 48-week and 5-year long-term efficacy follow-up results paper on this trial was selected as the best original research of 2021 by the OJSM (Orthopaedic Journal of Sports Medicine). OJSM is SCI-level journal of the AOSSM (American Orthopaedic Society for Sports Medicine).
01 Aug 2022 Status changed from active, no longer recruiting to completed.
11 Jun 2021 Planned End Date changed from 1 Dec 2021 to 1 Jun 2022.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com